Supporting the Future of Immunomodulatory Drugs


Achieve Critical Milestones in Your Drug Development Program

At Altasciences, we specialize in diverse immunomodulators, including proteins, oligonucleotides, biologics, bispecific antibodies, and gene therapy.

Our evaluations count on essential biomarkers, like cytokines, complement factors, immune cell subtyping, and functional measurements.

Rely on us for:

  • precise drug quantitation and biomarker assessment;
  • state-of-the-art bioanalytical platforms to monitor multiple aspects of immunomodulation in various species;
  • bioanalytical teams with relevant experience handling pathogens and working with infectious samples for your vaccine development programs; and
  • labs equipped with containment Level 2 (CL2) areas for handling pathogens within the Risk Group 2.


Need more guidance? Send us a message.


You may also be interested in the below resources:
Fact Sheet: Immunogenicity Testing
eBook: Key Biomarkers of Immunomodulation
Webpage: Bioanalytical Platforms